Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-12-16

EMA Authorised: Cyanokit (hydroxocobalamin) — SERB SA

View source ↗

Summary

The EMA authorised Cyanokit (hydroxocobalamin) in the EU for the treatment of cyanide poisoning. SERB SA is the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyanokit (hydroxocobalamin)

Snippet

Status: Authorised. Therapeutic area: Poisoning. MAH: SERB SA. Decision date: 16/12/2025